Skip to main content

Test Price

110 AED

✅ Home Collection Available

PSA (Prostate-Specific Antigen) Free Test in UAE | 110 AED | DNA Labs UAE

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139) using Chemiluminescent Microparticle Immunoassay (CMIA).
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — available daily 8 AM to 11 PM across all Emirates.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by qualified medical professionals under DHA-licensed supervision.
  • Insurance & Billing: Direct Billing Verification via WhatsApp at +971 54 548 8731 — instant confirmation within minutes.

Test Overview & Methodology

The PSA Free Test quantifies unbound prostate-specific antigen in serum, serving as a critical adjunct to total PSA for stratifying prostate cancer risk — particularly in men with total PSA levels between 4–10 ng/mL where the free-to-total ratio refines biopsy decision-making. This assay is performed using Chemiluminescent Microparticle Immunoassay (CMIA) on ISO 9001:2015 accredited platforms.

Parameter Our PSA Free Test Standard Total PSA Only
Precision CMIA – High-specificity free/total ratio analysis Total PSA only – lacks free fraction differentiation
Methodology Chemiluminescent Microparticle Immunoassay (CMIA), ISO-validated Variable immunoassay platforms, non-specialized
Turnaround Time Daily reporting – same-day results 24–72 hours typical

Physician Insight & Safety Protocols

A Note from Mr. Prabhakar Reddy Kalathoor (DHA Registration ID: 61713011, Specialist Diagnostic Radiology):

The PSA Free Test is a powerful risk-stratification tool, but it must always be interpreted alongside total PSA, digital rectal examination findings, and patient age — never in isolation. I urge every patient to understand that a single elevated value does not confirm malignancy, nor does a normal result fully exclude it; clinical correlation with a DHA-licensed specialist is essential.

This test is most clinically useful when the total PSA is in the diagnostic gray zone of 4–10 ng/mL, where a free PSA percentage below 10% significantly elevates the probability of detecting clinically significant prostate cancer on biopsy.

Medication Advisory

⚠ Important: Do not discontinue any prescribed medication — including 5-alpha reductase inhibitors (e.g., finasteride, dutasteride), anti-androgens, or hormonal therapies — without consulting your prescribing physician. These medications directly influence PSA levels, and abrupt cessation can confound clinical interpretation. Always inform your healthcare provider of all medications before testing.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria — Do NOT proceed with sample collection if:

  • Digital Rectal Examination (DRE) performed within the last 7 days.
  • Rectal prostatic ultrasonography performed within the last 7 days.
  • Active urinary tract infection (UTI) or acute prostatitis — wait at least 4–6 weeks post-resolution.
  • Prostate biopsy within the last 6 weeks.
  • Ejaculation within 48 hours prior to blood draw.

Emergency Red Flags — Seek immediate medical attention if:

  • Acute urinary retention or complete inability to urinate.
  • Visible blood in urine (frank hematuria) with clots.
  • Sudden onset severe lower back, pelvic, or perineal pain.
  • Unexplained rapid weight loss exceeding 5 kg in 4 weeks with bone pain.
  • New-onset lower extremity weakness or bowel/bladder incontinence.

Patient FAQ & Clinical Guidance

1. What does the PSA Free Test tell me that a standard total PSA test does not?

The free PSA fraction helps distinguish benign prostate enlargement from malignancy when total PSA falls between 4 and 10 ng/mL. A lower free PSA percentage — particularly below 10% — correlates with a higher probability of detecting clinically significant prostate cancer upon biopsy, while a percentage above 25% more strongly suggests benign prostatic hyperplasia (BPH). This differentiation reduces unnecessary biopsies by approximately 20–30% in appropriately selected patients.

2. Why must I wait 7 days after a digital rectal examination before giving a blood sample?

Digital rectal examination and rectal prostatic ultrasonography mechanically manipulate the prostate gland, causing a transient release of PSA into the bloodstream that can falsely elevate results by up to 30–50%. Waiting a full 7 days ensures that any iatrogenic PSA spike has cleared, yielding a result that accurately reflects your baseline prostatic physiology rather than procedural artifact.

3. How should I prepare for the PSA Free Test and what can I expect from the home collection service?

Preparation is straightforward: abstain from ejaculation for 48 hours prior, ensure no DRE or prostatic ultrasound has occurred within 7 days, and inform the phlebotomist of all medications including over-the-counter supplements. Our VIP mobile phlebotomy team arrives at your location with ISO-certified cold-chain transport, collects 2 mL of serum in a single SST tube, and delivers it to our DHA-licensed facility for same-day processing — with results typically available by evening.

UAE Regulatory & Data Privacy Adherence

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — All patient data processed, stored, and transmitted under UAE federal data privacy mandates.
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — Full compliance with health data handling and cybersecurity standards.
  • Federal Decree-Law No. 4 of 2016 on Medical Liability — Patient safety and clinical consent protocols strictly adhered to.
  • ISO 9001:2015 — Certified Quality Management System (Cert: INT/EGQ/2509DA/3139) for laboratory and logistics operations.
  • DHA Facility License: 1143 — Regulated by Dubai Health Authority.

Clinical & Logistical Metadata

Test Name PSA (Prostate-Specific Antigen) Free Test
Price (AED) 110 AED
Turnaround Time Same-day reporting
Sample Type / Matrix Serum (SST tube, 2 mL)
Methodology Used Chemiluminescent Microparticle Immunoassay (CMIA)
ICD-10-CM Code C61 (Malignant Neoplasm of Prostate), Z12.5 (Screening), R97.20 (Elevated PSA)
LOINC Code 10886-0 — Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
DHA Facility License & Address License: 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians